ISSN: 2165-7831
Journal of Blood & Lymph
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
 
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business
 

Unusual Bulky Presentation due to Missed Diagnosis of Hodgkin Lymphoma

Perrone Salvatore*, Molica Matteo, Massaro Fulvio, Capria Saveria, Martelli Maurizio and Foà Robin
Department of Cellular Biotechnologies and Hematology, “Sapienza” University, Rome, Italy
Corresponding Author : Perrone Salvatore
Department of Cellular Biotechnologies and Hematology
“Sapienza” University, Rome, Italy
Tel: (+39) 06 49911
E-mail: s.perrone@bce.uniroma1.it
Received March 06, 2015; Accepted March 20, 2015; Published April 03, 2015
Citation: Salvatore P, Matteo M, Fulvio M, Saveria C, Maurizio M, et al. (2015) Unusual Bulky Presentation due to Missed Diagnosis of Hodgkin Lymphoma. J Blood Lymph 5:135. doi: 10.4172/2165-7831.1000135
Copyright: © 2015 Salvatore P, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Blood & Lymph

Case Report
A 44-year-old woman was admitted to the emergency room presenting a voluminous neck and axillary tumor associated with an upper left limb swelling and progressively severe dyspnea. At triage, the patient stated that the swelling had presented itself about three years earlier and that during this time she had never sought medical care, had self-prescribed steroid medication and had managed to camouflage the bulky mass to her relatives. Clinical examination showed a massive swelling with evidence of mediastinal syndrome (venous distension of the neck, upper limb oedema, compensatory collateral circles and shortness of breath) (Figure 1).
Laboratory evaluation showed an increased neutrophil count (18.5×103/μl) and lymphopenia (0.45×103/μl), probably related to steroid abuse. Inflammatory markers were elevated, while LDH was only slightly increased (274 UI/l, UNL 225 UI/l). A total body, contrast-enhanced CT scan revealed bulky lymphadenopathy involving the left retro-mandibular, laterocervical and mediastinal districts (75×65 mm), as well as left axilla (80×80 and 90×120 mm) dislocating the local vascular structures. The mass also involved the left breast and resulted in severe compression of the left lung (Figure 2). Due to hemodynamic instability, only a core needle biopsy could be performed. Histopathological examination documented the presence of Reed-Sternberg cells (CD30+, CD15-/+, CD20+/-, PAX-5+, CD45-, CD3-, CD68-, ALK-), diagnostic of a classical sclero-nodular Hodgkin lymphoma (HL). After the first course of ABVD (doxorubicin, bleomicin, vinblastine, dacarbazine), the clinical conditions improved with reduced dyspnea and visible shrinking of the mass. Unfortunately, 20 days later, the patient developed left-arm cellulitis and pneumonia that rapidly precipitated into irreversible septic shock by multidrug-resistant Acinetobacter baumannii.
HL accounts for approximately 0.6% of all new cancer cases in the USA. It is unique in that the neoplastic Hodgkin and Reed–Sternberg (HRS) cells of classical HL account for only 1% of the tumor tissue in most cases, with various inflammatory cells comprising the tumor microenvironment. Recent research has identified that HRS cells originate from germinal center B-cells [1].
In present days, characterized by early diagnosis and advanced medical techniques, the presentation of a ‘visible’ lymphoma with a 3- year delay appears rather remarkable, particularly in a country like Italy where the National Health System makes medical care available at no cost to all patients. The patient’s habitus is reminiscent of the early days cases reported by Thomas Hodgkin in 1832, at a time when no effective treatment was available. At diagnosis, HL patients are staged using the Ann Arbor System [2] and divided into 2 groups: those with limited-stage disease, typically including those with stage I or II disease (Involvement of 2 or more lymph node regions on the same side of the diaphragm); and those with advanced-stage (stage III or IV) disease.
Another interesting aspect of this case is that, despite the massive tumour mass and the years that elapsed from presentation to diagnosis, the lymphoma still had a limited stage II. To date, studies have established chemotherapy and involved-field radiotherapy (IFRT) as standard therapy in limited stages disease: 2 cycles of ABVD followed by 20 Gy for early favorable HL (according to the German Hodgkin Study Group criteria: No large mediastinal adenopathy, No Extra Nodal disease, 1-2 involved nodal regions, ESR ≤ of 50 mm/hr) [3]; 4 cycles of ABVD plus 30 Gy for those with risk factors [4], like our patient. The outcome achieved by primary treatment with ABVD in major clinical trials and large single-institution series has improved over the years from the late 1980s through the early 2000s with a 5- year OS rate increased from just over 70% to approximately 90% [5].
In conclusion, it is likely that this woman lived with the stigma of having cancer, hiding her tumor and endangering her life, for a condition otherwise highly curable.
References
Select your language of interest to view the total content in your interested language
 
Share This Article
   
 
   
 
Relevant Topics
Disc
Disc Acute Lymphoblastic Leukemia
Disc Acute Megakaryocytic Leukemia
Disc Acute Myelomonocytic Leukemia
Disc Acute Myleoid Leukemia
Disc Adenocarcinoma pancreas
Disc Advances in Alternative Lung Cancer Treatment
Disc Aleukemic Leukemia
Disc Anaemia Symptoms
Disc Anemia Causes
Disc Anti-Cancer Drug
Disc Anxiety Medicine
Disc Apoptosis
Disc Biology of Cancer
Disc Biomolecular Structure and Function
Disc Bipolar Medicine
Disc Bladder Carcinoma in Situ
Disc Blood
Disc Blood Cancer Symptoms
Disc Blood Clot in Brain
Disc Blood Clots
Disc Bone Cancer Stages
Disc Bone Marrow Cancer Survival
Disc Brain Tumor Treatment
Disc Breast Cancer Surgery
Disc Cancer Immunoediting
Disc Cancer Immunology
Disc Cancer Immunotherapies
Disc Cancer Radioimmunotherapy
Disc Cancer Science
Disc Cancer Therapies
Disc Cancer initiation and progression
Disc Carcinogenesis
Disc Cell Biology Junctions
Disc Cell Biology Techniques
Disc Cell Cycle
Disc Cell Death: Apoptosis
Disc Cell Regeneration
Disc Cell synthesis
Disc Cellular Biology
Disc Cellular DNA Studies
Disc Cellular Dynamics
Disc Cellular Immunotherapy
Disc Cellular Signalling
Disc Cellular and Molecular Biology
Disc Chemotherapies
Disc Chronic Lymphocytic Leukemia
Disc Chronic Myleloid Leukemia
Disc Colon Cancer Surgery
Disc DNA damage
Disc Depression Medicine
Disc Dermatologic Surgery
Disc Diabetic Medicine
Disc Ductal adenocarcinoma
Disc Esophageal Cancer
Disc Evolutionary Biology
Disc Factor XIII
Disc Feline Leukemia Complex
Disc Gene Expression and Regulation
Disc Germ cell tumours
Disc Haematologist
Disc Haemophilia
Disc Hairy Cell Leukemia
Disc Human Biology
Disc Immune Suppression
Disc Immunogene response
Disc Immunosurveillance
Disc Immunotherapeutic agents
Disc Immunotherapy or biologic therapy
Disc Iron Test
Disc Kidney Cancer Prognosis
Disc Kidney Cancer Surgery
Disc Large Cell Lymphoma
Disc Leukemia
Disc Leukemia Drugs
Disc Leukemia Surgery
Disc Leukemia Symptoms
Disc Lung Cancer Surgery
Disc Lung Tumor
Disc Lungs Cancer Cure
Disc Lymph Node Cancer
Disc Lymphoma Cancer
Disc Lymphoma Surgery
Disc Lymphoma Symptoms
Disc Lymphomatous polyposis
Disc Lymphosarcoma
Disc Mast Cell Leukemia
Disc Metastatic Cancer
Disc Methods and Techniques in Molecular Biology
Disc Molecular Biochemistry
Disc Molecular Biotechnology
Disc Molecular Cell
Disc Molecular Genetics
Disc Morbus Hodgkin
Disc Multiple Myeloma
Disc Mutagenesis
Disc Myeloma
Disc Necrosis
Disc Nucleic Acid Research
Disc Oesophageal Cancer Surgery
Disc Oseophagus Cancer
Disc Ovarian Cancer and Prognosis
Disc Pancreatic Cancer
Disc Pancreatic Cancer Surgery
Disc Pediatric Leukemia
Disc Photo carcinogenesis
Disc Plasma Cell Leukemia
Disc Prostate Cancer Surgery
Disc Radiation Therapy
Disc Sarcoma Cancer
Disc Sickle Cell Trait
Disc Skin Cancer Surgery
Disc Spleen Cancer
Disc Stem Cell Biology
Disc Stomach Cancer Surgery
Disc Systems of Immune
Disc T-cell Lymphomas
Disc Throat Cancer Surgery
Disc Thyroid Cancer Surgery
Disc Transitional cell carcinoma (TCC)
Disc Tumor Immunity
Disc Tumour Immunity
Disc Tumour Immunology
 
Recommended Journals
Disc Cancer Science
Disc Clinical Journals
Disc Pediatric Oncology Journal
Disc Mutagenesis Journal
Disc Carcinogenesis Journal
Disc Leukemia Journal
Disc Immunooncology Journal
Disc Cellular and Molecular Biology Journal
Disc Biology and Medicine Journal
Disc Cancer Surgery Journal
  View More»
 
Recommended Conferences
Disc Leukemia and Bone Marrow Transplantation Conference
November 10-12, 2016 Istanbul, Turkey
 
Article Tools
Disc Export citation
Disc Share/Blog this article
 
Article usage
  Total views: 11179
  [From(publication date):
April-2015 - Jun 29, 2016]
  Breakdown by view type
  HTML page views : 7448
  PDF downloads :3731
 
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

 
OMICS International Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
 
 
OMICS International Conferences 2016-17
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings
 
 

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsinc.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsinc.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsinc.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsinc.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsinc.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsinc.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsinc.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsinc.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsinc.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsinc.com

1-702-714-7001Extn: 9039

Materials Science Journals

Rachle Green

materialsci@omicsinc.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsinc.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsinc.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsinc.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsinc.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsinc.com

1-702-714-7001 Extn: 9042

 
© 2008-2016 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version